Follow-up Neutrophil–Lymphocyte Ratio as a Predictor for Postoperative Pneumonia After Endovascular Treatment in Aneurysmal Subarachnoid Hemorrhage Patients: A Retrospective Analysis

Author:

Huang Xinyue1,Guo Xiumei1,Gao Wen1,Guo Liming1,Xiong Yu1,Chen Chunhui1,Zheng Hanlin1,Pan Zhigang1,Lin Qingxin1,Zheng Shuni1,Ke Chuhan1,Hu Weipeng1,Zheng Feng1

Affiliation:

1. Fujian Medical University

Abstract

Abstract The association between NLR and postoperative pneumonia (POP) in patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent endovascular treatment remains poorly understood. Patients with aSAH who underwent endovascular treatment between January 2019 and April 2023 were included. The follow-up endpoint was the presence of POP at 30 days postoperatively. Logistic regression analysis was conducted using POP as the dependent variable. NLR was calculated at admission (NLR1), 24 h after endovascular treatment (NLR2), and 3–7 days after endovascular treatment (NLR3). Four prediction models were constructed: Model 1 (variables with p < 0.05, except for the NLR); Model 2 (Model 1 plus NLR1); Model 3 (Model 1 plus NLR2); and Model 4 (Model 1 plus NLR3). Among the 154 patients with aSAH, POP occurred in 101 (65.6%) patients. Higher NLRs at admission (odds ratio [OR] = 1.08; 95% Confidence Interval [CI] 1.02, 1.16; p = 0.019), 24 h postoperatively (OR = 1.14; 95% CI 1.05, 1.25; p = 0.005) and 3-7days postoperatively (OR = 1.17; 95% CI 1.02, 1.38; p = 0.04) were independently associated with the occurrence of POP. Follow-up NLR may be an independent predictor of POP in aSAH patients treated endovascularly. Elevated NLR at admission, 24 h postoperatively and 3–7 days postoperatively correlated with a high risk for POP.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3